Managing Adult Acute and Acute-on-Chronic Liver Failure in the ICU.
作者信息
Han Xuan, Davis Andrew M, Parker William F
机构信息
Section of Pulmonary and Critical Care, University of Chicago, Chicago, Illinois.
Section of General Internal Medicine, University of Chicago, Chicago, Illinois.
出版信息
JAMA. 2021 Nov 16;326(19):1964-1965. doi: 10.1001/jama.2021.12742.
Abstract
摘要
相似文献
1
Managing Adult Acute and Acute-on-Chronic Liver Failure in the ICU.
JAMA. 2021 Nov 16;326(19):1964-1965. doi: 10.1001/jama.2021.12742.
2
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary and Renal Considerations: Executive Summary.
Crit Care Med. 2020 Mar;48(3):415-419. doi: 10.1097/CCM.0000000000004193.
3
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations.
Crit Care Med. 2020 Mar;48(3):e173-e191. doi: 10.1097/CCM.0000000000004192.
4
Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement.
BMJ. 2013 Jul 30;347:f4651. doi: 10.1136/bmj.f4651.
5
Hydroxyethyl starch for fluid resuscitation in critically ill patients.
Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.
6
[Acute Liver Failure, Acute-On-Chronic Liver Failure, Hepatorenal Syndrome, Hepatopulmonary Syndrome and Portopulmonary Hypertension, Artificial Liver Support on the ICU].
Zentralbl Chir. 2017 Jun;142(3):275-286. doi: 10.1055/s-0043-106198. Epub 2017 Jun 22.
7
[Liver diseases in the intensive care unit].
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):449-457. doi: 10.1007/s00063-024-01157-5. Epub 2024 Jun 27.
8
[Volume therapy: hydroxyethyl starch or saline? Hydroxyethyl starch in intensive care patients: there's an end of it!].
Dtsch Med Wochenschr. 2013 Jan;138(3):66. doi: 10.1055/s-0032-1329033. Epub 2013 Jan 8.
9
Hydroxyethyl starch or saline in intensive care.
N Engl J Med. 2013 Feb 21;368(8):774. doi: 10.1056/NEJMc1215977.
10
Hydroxyethyl starch or saline in intensive care.
N Engl J Med. 2013 Feb 21;368(8):774-5. doi: 10.1056/NEJMc1215977.
引用本文的文献
1
The Predictive Role of FGF21 in Acute Liver Injury Caused by Bacterial Infectious Diseases in Critical Care: A Retrospective Cohort Study.
J Inflamm Res. 2025 May 26;18:6795-6806. doi: 10.2147/JIR.S521327. eCollection 2025.
2
Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice.
Nutrients. 2023 Feb 24;15(5):1149. doi: 10.3390/nu15051149.
3
Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.
Trauma Surg Acute Care Open. 2022 Aug 1;7(1):e000936. doi: 10.1136/tsaco-2022-000936. eCollection 2022.
4
Alanyl-Glutamine Protects against Lipopolysaccharide-Induced Liver Injury in Mice via Alleviating Oxidative Stress, Inhibiting Inflammation, and Regulating Autophagy.
Antioxidants (Basel). 2022 May 27;11(6):1070. doi: 10.3390/antiox11061070.
本文引用的文献
1
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
2
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary and Renal Considerations: Executive Summary.
Crit Care Med. 2020 Mar;48(3):415-419. doi: 10.1097/CCM.0000000000004193.
3
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives.
Gut Liver. 2020 May 15;14(3):306-315. doi: 10.5009/gnl18412.
4
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005162. doi: 10.1002/14651858.CD005162.pub4.
5
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial.
Hepatology. 2016 Feb;63(2):566-73. doi: 10.1002/hep.28148. Epub 2015 Dec 9.
6
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
PLoS One. 2015 Aug 3;10(8):e0129305. doi: 10.1371/journal.pone.0129305. eCollection 2015.
7
Fluid resuscitation in sepsis: a systematic review and network meta-analysis.
Ann Intern Med. 2014 Sep 2;161(5):347-55. doi: 10.7326/M14-0178.
8
Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis.
J Crit Care. 2014 Apr;29(2):316.e7-12. doi: 10.1016/j.jcrc.2013.11.002. Epub 2013 Nov 7.
9
Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.
BMJ. 2013 Feb 15;346:f839. doi: 10.1136/bmj.f839.
10
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
N Engl J Med. 2012 Aug 23;367(8):716-24. doi: 10.1056/NEJMoa1110709.
Zotero 插件